Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Sales: 2021-2024

Historic Return on Sales for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -0.48%.

  • Biofrontera's Return on Sales fell 11.00% to -0.47% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.47%, marking a year-over-year decrease of 11.00%. This contributed to the annual value of -0.48% for FY2024, which is 12.00% up from last year.
  • Per Biofrontera's latest filing, its Return on Sales stood at -0.48% for FY2024, which was up 19.46% from -0.59% recorded in FY2023.
  • Over the past 5 years, Biofrontera's Return on Sales peaked at -0.02% during FY2022, and registered a low of -1.56% during FY2021.
  • Its 3-year average for Return on Sales is -0.36%, with a median of -0.48% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 154bps in 2022, then tumbled by 57bps in 2023.
  • Over the past 4 years, Biofrontera's Return on Sales (Yearly) stood at -1.56% in 2021, then surged by 154bps to -0.02% in 2022, then tumbled by 57bps to -0.59% in 2023, then climbed by 12bps to -0.48% in 2024.